— A THESIS-DRIVEN INVESTMENT FIRM
Fundamentally restructuring the critical industries we can no longer afford to get wrong.
From healthcare to cybersecurity and beyond — if a system is fragmented, we set out to fix it.
We don't have an effort problem. We have an outcome problem.
We've spent years solving the world's most urgent and expensive problems in pieces — and fragmentation poisons progress. Critical industries don't need more effort. They need integration.
This is why we exist.
Our capital powers business units. Our shared infrastructure makes them perform.
WHAT WE’RE DOING
Own & operate
Controlling stakes in a long-term portfolio of thesis-driven companies, with shared financial upside.
HOW WE DO IT
Vertically integrate
Businesses brought into unified ecosystems that make fragmented models obsolete.
Our model.
The right investments. The right moments. The right reasons.
01
Target the industry
The mission-critical sectors feeling the full pressure of fragmentation.
02
Invest in opportunity
Own and operate companies that contribute to the industry.
03
Integrate vertically
For a unified, amplified ecosystem.
04
Deploy capital
Through a range of investment avenues.
05
Focus forward
For long-term, compounding growth.
06
Rigorous measurement
Because we’re only in this for results.
Healthcare and security are among the most critical of spaces. We're tackling them first — beginning with Karma Health, Integrative Medicine.
Leadership.
Operators, clinicians, financiers, and public servants who have built across sectors and cycles.
Patrice Bonfiglio
CEO & Co-Founder
Two decades at the intersection of healthcare and capital. Former President of Sarissa Capital Management and an Independent Director of Amarin Corporation (Nasdaq: AMRN); founder of The Bedrock Institute.
Eric Rosado
Chief Strategy Officer & Co-Founder
Two decades building technology-enabled healthcare platforms and cross-border commercial initiatives. Leads enterprise strategy and coordination between operating businesses and capital partners.
Nilesh Patel
Chief Financial Officer
Led finance and portfolio strategy for U.S. investments at Devonshire Investors, the private-equity arm of Fidelity. Prior roles in the Office of the CFO at IBM and at Booz Allen Hamilton. MBA, Columbia.
Dr. Kristine Blanche, PA-C, PhD
Chief Medical Officer
Nearly two decades in Emergency Medicine, Surgery, and Critical Care at George Washington University and Northwell Health. Holds both an MD and PhD; a recognized leader in functional and integrative medicine.
Romulad Beneche
Head of Investor Relations
More than 26 years in alternative investments — as auditor, controller, senior relationship manager, and business-development director — advising managers on operational efficiency and capital raising.
Marianne Rosado
Chief Real Estate Officer
21+ years across capital markets, international real estate, and healthcare operations. Architects the group's physical and strategic footprint. B.S., Cornell; MBA, University of Miami.
See what can be done, now.
For partnership, capital, and ecosystem enquiries — we'd like to hear from you.
ENQUIRIES
OFFICES
Washington DC · Miami